indiamarketoutlook

Aurobindo Pharma: Will the medicine work this time???

Largo
indiamarketoutlook Actualizado   
NSE:AUROPHARMA   AUROBINDO PHARMA
Aurobindo

Observations

- has been sideways since May 16, 2022
- stock has moved past 20 day EMA
- stock has crossed 50 day EMA
- the stock is on the verge of breaking range bound channel
- sustaining above 552 is going to be the key
-target for the set up 612 / 630

Consider buying 570 Call Option at cmp & /or on dips in Spot Aurobindo Pharma around 552
Target 33 / 42

Do proper risk management

Disclaimer
- The view expressed here is my personal view
- Past performance is not a guarantee for future predictions
- Use this for educational purpose
- Any decision you take, you need to take responsibility for the same
- It's your hard earned money. Treat it wisely
- Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance
- if trading in F&O, understand that F&O trading involves risk
- Do take proper risk management measures
- Do your own analysis and consult your financial adviser if need be
Operación activa:

The stock has come to 50 day EMA
As suggested above
Have Bought 570 Call Option

Take care & safe trading...!!!

Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.